147 related articles for article (PubMed ID: 31280582)
1. HIVfird: A Tool for Detection of Resistance to Fusion Inhibitor Drugs in HIV-1 Sequences.
Barreto Vasconcelos AL; Monteiro-Cunha JP
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):941-947. PubMed ID: 31280582
[TBL] [Abstract][Full Text] [Related]
2. Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro.
Mink M; Mosier SM; Janumpalli S; Davison D; Jin L; Melby T; Sista P; Erickson J; Lambert D; Stanfield-Oakley SA; Salgo M; Cammack N; Matthews T; Greenberg ML
J Virol; 2005 Oct; 79(19):12447-54. PubMed ID: 16160172
[TBL] [Abstract][Full Text] [Related]
3. Enfuvirtide (T-20) resistance-related mutations in HIV type 1 subtypes B, C, and F isolates from Brazilian patients failing HAART.
Oliveira AC; Martins AN; Pires AF; Arruda MB; Tanuri A; Pereira HS; Brindeiro RM
AIDS Res Hum Retroviruses; 2009 Feb; 25(2):193-8. PubMed ID: 19239358
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring resistance mutations to HIV-1 entry inhibitors in subtypes B, C, and CRF31_BC.
Araújo LA; Junqueira DM; de Medeiros RM; Matte MC; Almeida SE
J Clin Virol; 2012 May; 54(1):6-10. PubMed ID: 22336085
[TBL] [Abstract][Full Text] [Related]
5. Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.
Sista PR; Melby T; Davison D; Jin L; Mosier S; Mink M; Nelson EL; DeMasi R; Cammack N; Salgo MP; Matthews TJ; Greenberg ML
AIDS; 2004 Sep; 18(13):1787-94. PubMed ID: 15316339
[TBL] [Abstract][Full Text] [Related]
6. In vitro generation of HIV type 1 subtype C isolates resistant to enfuvirtide.
Cilliers T; Moore P; Coetzer M; Morris L
AIDS Res Hum Retroviruses; 2005 Sep; 21(9):776-83. PubMed ID: 16218801
[TBL] [Abstract][Full Text] [Related]
7. Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.
Menzo S; Castagna A; Monachetti A; Hasson H; Danise A; Carini E; Bagnarelli P; Lazzarin A; Clementi M
New Microbiol; 2004 Apr; 27(2 Suppl 1):51-61. PubMed ID: 15646065
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo City, Mozambique.
Ismael N; Bila D; Mariani D; Vubil A; Mabunda N; Abreu C; Jani I; Tanuri A
AIDS Res Hum Retroviruses; 2014 Jun; 30(6):603-9. PubMed ID: 24188582
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy.
Poveda E; Rodés B; Lebel-Binay S; Faudon JL; Jimenez V; Soriano V
J Clin Virol; 2005 Dec; 34(4):295-301. PubMed ID: 16286053
[TBL] [Abstract][Full Text] [Related]
10. Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors.
Hudelson SE; Marlowe N; Huang W; Bruce R; Church JD; Husnik M; Donnell D; Coates T; Jackson JB; Chesney M; Koblin B; Eshleman SH
AIDS Res Hum Retroviruses; 2009 Jul; 25(7):701-5. PubMed ID: 19552592
[TBL] [Abstract][Full Text] [Related]
11. Genotypic changes in human immunodeficiency virus type 1 envelope glycoproteins on treatment with the fusion inhibitor enfuvirtide and their influence on changes in drug susceptibility in vitro.
Su C; Melby T; DeMasi R; Ravindran P; Heilek-Snyder G
J Clin Virol; 2006 Aug; 36(4):249-57. PubMed ID: 16765082
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy.
Poveda E; Briz V; Paraskevis D; Barreiro P; Hatzakis A; Soriano V
AIDS Res Hum Retroviruses; 2007 Sep; 23(9):1078-82. PubMed ID: 17919101
[TBL] [Abstract][Full Text] [Related]
13. gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure.
D'Arrigo R; Ciccozzi M; Gori C; Montieri S; Aquaro S; Bellagamba R; Boumis E; Di Perri G; Pizzi D; Antinori A; Rezza G; Perno CF
AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1296-302. PubMed ID: 17961119
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 gp41 genetic diversity and enfuvirtide resistance-associated mutations among enfuvirtide-naïve patients in southern China.
Chang L; Zhao J; Guo F; Ji H; Zhang L; Jiang X; Wang L
Virus Res; 2021 Jan; 292():198215. PubMed ID: 33166562
[TBL] [Abstract][Full Text] [Related]
15. Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide.
Loutfy MR; Raboud JM; Montaner JS; Antoniou T; Wynhoven B; Smaill F; Rouleau D; Gill J; Schlech W; Brumme ZL; Mo T; Gough K; Rachlis A; Harrigan PR; Walmsley SL
Antiviral Res; 2007 Jul; 75(1):58-63. PubMed ID: 17196268
[TBL] [Abstract][Full Text] [Related]
16. Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.
Cabrera C; Marfil S; García E; Martinez-Picado J; Bonjoch A; Bofill M; Moreno S; Ribera E; Domingo P; Clotet B; Ruiz L
AIDS; 2006 Oct; 20(16):2075-80. PubMed ID: 17053353
[TBL] [Abstract][Full Text] [Related]
17. Genotypic analysis of the gp41 HR1 region from HIV-1 isolates from enfuvirtide-treated and untreated patients.
Pessoa LS; Valadão AL; Abreu CM; Calazans AR; Martins AN; Azevedo SS; Couto-Fernandez JC; Azevedo MC; Tanuri A
J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3():S197-201. PubMed ID: 21857318
[TBL] [Abstract][Full Text] [Related]
18. Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients.
Labrosse B; Morand-Joubert L; Goubard A; Rochas S; Labernardière JL; Pacanowski J; Meynard JL; Hance AJ; Clavel F; Mammano F
J Virol; 2006 Sep; 80(17):8807-19. PubMed ID: 16912327
[TBL] [Abstract][Full Text] [Related]
19. Short communication: high polymorphism rates in the HR1 and HR2 gp41 and presence of primary resistance-related mutations in HIV type 1 circulating in Brazil: possible impact on enfuvirtide efficacy.
Teixeira C; de Sá-Filho D; Alkmim W; Janini LM; Diaz RS; Komninakis S
AIDS Res Hum Retroviruses; 2010 Mar; 26(3):307-11. PubMed ID: 20334566
[TBL] [Abstract][Full Text] [Related]
20. Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains.
Roman F; Gonzalez D; Lambert C; Deroo S; Fischer A; Baurith T; Staub T; Boulmé R; Arendt V; Schneider F; Hemmer R; Schmit JC
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):134-9. PubMed ID: 12794544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
